• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[人白血病细胞中原癌基因c-abl的扩增与重排]

[Amplification and rearrangement of proto-oncogene c-abl in human leukemia cells].

作者信息

Jin X M, Miao J, Xu Y, Deng G R

机构信息

Beijing Cancer Institute, Beijing.

出版信息

Zhonghua Zhong Liu Za Zhi. 1988 May;10(3):167-70.

PMID:3219975
Abstract

DNA of peripheral blood or bone marrow leukocytes from 8 normal subjects, 7 cases of acute lymphocytic leukemia (ALL), 2 of acute myelogenous leukemia (AML) and 1 of chronic myelogenous leukemia (CML), having been digested by endonuclease Eco RI or Pst I separately, was hybridized with the probes of 3' fragment (Pst I/Hind III) or 5' fragment (Hinc II/Pst I) of Abelson murine leukemia virus (A-MuLV) oncogene v-abl. The proto-oncogene c-abl, which is homologous to v-abl, was found amplified in 4 ALL, 1 CML and 1 AML. In one of these 4 ALL, c-abl was amplified even over 100 times. A new c-abl BamH I fragment with 6.7 kilobase pairs (kb) in length was observed in 2 ALL and 1 CML out of these 6 cases with amplification, but none of this fragment was found in the normal subjects or other leukemia patients. These 3 patients with the presence of 6.7 kb fragment were high risk ones and 2 of them had died, suggesting that 6.7 kb fragment be the index of poor prognosis. The amplification and rearrangement of c-abl imply the activation of proto-oncogene in leukemogenesis.

摘要

分别用内切酶Eco RI或Pst I消化8名正常受试者、7例急性淋巴细胞白血病(ALL)、2例急性髓细胞白血病(AML)和1例慢性髓细胞白血病(CML)的外周血或骨髓白细胞的DNA,然后与Abelson鼠白血病病毒(A-MuLV)癌基因v-abl的3'片段(Pst I/Hind III)或5'片段(Hinc II/Pst I)探针杂交。发现与v-abl同源的原癌基因c-abl在4例ALL、1例CML和1例AML中发生扩增。在这4例ALL中的1例中,c-abl扩增甚至超过100倍。在这6例发生扩增的病例中的2例ALL和1例CML中观察到一个新的长度为6.7千碱基对(kb)的c-abl BamH I片段,但在正常受试者或其他白血病患者中均未发现该片段。这3例存在6.7 kb片段的患者为高危患者,其中2例已死亡,提示6.7 kb片段是预后不良的指标。c-abl的扩增和重排意味着原癌基因在白血病发生过程中被激活。

相似文献

1
[Amplification and rearrangement of proto-oncogene c-abl in human leukemia cells].[人白血病细胞中原癌基因c-abl的扩增与重排]
Zhonghua Zhong Liu Za Zhi. 1988 May;10(3):167-70.
2
Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.人类c-abl基因的多态性:与慢性粒细胞白血病的发病率及病程的关系
Oncogene. 1987 May;1(2):193-200.
3
Further evidence of the involvement of the c-abl oncogene in chronic myelogenous leukemia and acute lymphocytic leukemia.关于c-abl癌基因参与慢性粒细胞白血病和急性淋巴细胞白血病的进一步证据。
Mol Biol Med. 1988 Dec;5(3):139-44.
4
Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.双色-双融合易位荧光原位杂交技术检测bcr/abl融合基因的临床意义
Zhonghua Zhong Liu Za Zhi. 2002 Jul;24(4):364-6.
5
[The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].[bcr/abl重排在慢性髓性白血病诊断及病情进展中的应用价值]
Med Clin (Barc). 1993 Oct 30;101(14):521-4.
6
Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.一名处于良性期慢性粒细胞白血病患者的急性淋巴细胞白血病分子表型
Hematol Pathol. 1993;7(2):91-106.
7
Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.与v-Abl相比,Bcr-Abl具有更强的内在能力来诱导髓系细胞的肿瘤性增殖。
Oncogene. 2000 Dec 14;19(54):6286-96. doi: 10.1038/sj.onc.1204023.
8
Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.青少年慢性粒细胞白血病中的断点簇集区、免疫球蛋白及T细胞受体基因重排分析
Mod Pathol. 1995 May;8(4):389-93.
9
Analysis of A-MuLV transformed fibroblast lines for amplification of the c-myc, p53 and c-fos nuclear proto-oncogenes.分析A-MuLV转化的成纤维细胞系中c-myc、p53和c-fos核原癌基因的扩增情况。
Oncogene. 1989 Jun;4(6):753-7.
10
ABL oncogenes and phosphoinositide 3-kinase: mechanism of activation and downstream effectors.ABL癌基因与磷酸肌醇3激酶:激活机制及下游效应分子
Cancer Res. 2005 Mar 15;65(6):2047-53. doi: 10.1158/0008-5472.CAN-04-3888.